Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
MicroRNAs (miRNAs) are increasingly recognized to play crucial roles in regulation of gene expression in different biological events, including many sporadic forms of cancer. However, despite the involvement of several viruses in inducing cancer, only a limited number of studies have been carried out to examine the miRNA expression signatures in virus-induced neoplasia, particularly in herpesvirus-induced tumours where virus-encoded miRNAs also contribute significantly to the miRNome of the tumour cell. Marek's disease (MD) is a naturally occurring, rapid-onset CD4+T-cell lymphoma of poultry, induced by the highly contagious Marek's disease virus (MDV). High levels of expression of virus-encoded miRNAs and altered expression of several host-encoded miRNAs were demonstrated in the MDV-transformed lymphoblastoid cell line MSB-1. In order to identify the miRNA expression signature specific to MDV-transformed cells, we examined the global miRNA expression profiles in seven distinct MDV-transformed cell lines by microarray analysis. This study revealed that, in addition to the high levels of MDV-encoded miRNAs, these MD tumour-derived lymphoblastoid cell lines showed altered expression of several host-encoded miRNAs. Comparison of the miRNA expression profiles of these cell lines with the MDV-negative, retrovirus-transformed AVOL-1 cell line showed that miR-150 and miR-223 are downregulated irrespective of the viral aetiology, whereas downregulation of miR-155 was specific for MDV-transformed tumour cells. Thus, increased expression of MDV-encoded miRNAs with specific downregulation of miR-155 can be considered as unique expression signatures for MD tumour cells. Analysis of the functional targets of these miRNAs would contribute to the understanding of the molecular pathways of MD oncogenicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In chicken T cells, both Marek's disease (MD) and overexpressed lnc-GALMD3 result in low miR-223 expression, leading to malignant T cell proliferation 49,50.”
From miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation (2021) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626
Regulation of progenitor cell proliferation and granulocyte function by microRNA-223
Johnnidis, J. B., Harris, M. H., Wheeler, R. T., Stehling-Sun, S., Lam, M. H., Kirak, O., Brummelkamp, T. R., Fleming, M. D., & Camargo, F. D. (2008) · Nature · doi:10.1038/nature06607 · Cited by 1,208
Differential expression of microRNAs in hematopoietic cell lineages
Merkerova, M., Belickova, M., & Bruchova, H. (2008) · European Journal of Haematology · doi:10.1111/j.1600-0609.2008.01111.x · Cited by 240 · cited 1×
“In the case of miR223, although all of the regulatory mechanisms are not yet understood fully, recent studies have indicated a clear role for miR-223 in haematopoiesis, as well as in malignancies (Baek et al., 2008; Garzon & Croce, 2008; Johnnidis et al., 2008; Merkerova et al., 2008).”
Background
Research works printed but not linked: 50
- Akiyama, 1974, Two cell lines from lymphomas of Marek's disease, Biken J, 17, 105
- Baek, 2008, The impact of microRNAs on protein output, Nature, 455, 64, 10.1038/nature07242 · DOI · Paper page
- Bornkamm, 2005, Stringent doxycycline-dependent control of gene activities using an episomal one-vector system, Nucleic Acids Res, 33, e137, 10.1093/nar/gni137 · DOI
- Burnside, 2007, Genomics and Marek's disease virus, Cytogenet Genome Res, 117, 376, 10.1159/000103201 · DOI
- Burnside, 2006, Marek's disease virus encodes microRNAs that map to meq and the latency-associated transcript, J Virol, 80, 8778, 10.1128/JVI.00831-06 · DOI · Paper page
- Burnside, 2008, Deep sequencing of chicken microRNAs, BMC Genomics, 9, 185, 10.1186/1471-2164-9-185 · DOI
- Cai, 2005, Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells, Proc Natl Acad Sci U S A, 102, 5570, 10.1073/pnas.0408192102 · DOI · Paper page
- Calin, 2006, MicroRNA signatures in human cancers, Nat Rev Cancer, 6, 857, 10.1038/nrc1997 · DOI · Paper page
- Calin, 2007, Investigation of microRNA alterations in leukemias and lymphomas, Methods Enzymol, 427, 193
- Calnek, 1986, Marek's disease: a model for herpesvirus oncology, Crit Rev Microbiol, 12, 293, 10.3109/10408418509104432 · DOI
- Chan, 1988, Identification of the avian homologues of mammalian CD4 and CD8 antigens, J Immunol, 140, 2133, 10.4049/jimmunol.140.7.2133 · DOI · Paper page
- Cosmopoulos, 2008, Comprehensive profiling of EBV microRNAs in nasopharyngeal carcinoma, J Virol, 83, 2357, 10.1128/JVI.02104-08 · DOI · Paper page
- Cullen, 2006, Viruses and microRNAs, Nat Genet, 38, S25, 10.1038/ng1793 · DOI · Paper page
- Cullen, 2009, Viral and cellular messenger RNA targets of viral microRNAs, Nature, 457, 421, 10.1038/nature07757 · DOI · Paper page
- Fabbri, 2008, MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications, Leukemia, 22, 1095, 10.1038/leu.2008.30 · DOI
- Garcia, 2008, Hematopoietic lineage commitment: miRNAs add specificity to a widely expressed transcription factor, Dev Cell, 14, 815, 10.1016/j.devcel.2008.05.011 · DOI
- Garzon, 2008, MicroRNAs in normal and malignant hematopoiesis, Curr Opin Hematol, 15, 352, 10.1097/MOH.0b013e328303e15d · DOI · Paper page
- Ghosh, 2008, Cellular versus viral microRNAs in host–virus interaction, Nucleic Acids Res, 37, 1035, 10.1093/nar/gkn1004 · DOI · Paper page
- Gottwein, 2008, Viral and cellular microRNAs as determinants of viral pathogenesis and immunity, Cell Host Microbe, 3, 375, 10.1016/j.chom.2008.05.002 · DOI · Paper page
- Griffiths-Jones, 2008, miRBase: tools for microRNA genomics, Nucleic Acids Res, 36, D154, 10.1093/nar/gkm952 · DOI · Paper page
- Javier, 2008, The history of tumor virology, Cancer Res, 68, 7693, 10.1158/0008-5472.CAN-08-3301 · DOI · Paper page
- Lambeth, 2009, MicroRNAs 221 and 222 target p27Kip1 in Marek's disease virus-transformed tumour cell line MSB-1, J Gen Virol, 90, 1164, 10.1099/vir.0.007831-0 · doi:10.1099/vir.0.007831-0
- Lawrie, 2007, MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma, Int J Cancer, 121, 1156, 10.1002/ijc.22800 · DOI · Paper page
- Lawrie, 2008, MicroRNA expression in lymphocyte development and malignancy, Leukemia, 22, 1440, 10.1038/sj.leu.2405083 · DOI
- Lee, 2009, MicroRNAs in cancer, Annu Rev Pathol, 4, 199, 10.1146/annurev.pathol.4.110807.092222 · DOI · Paper page
- Lin, 2008, c-Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development, Mol Biol Evol, 25, 2189, 10.1093/molbev/msn165 · DOI
- Lowery, 2008, MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management, Clin Cancer Res, 14, 360, 10.1158/1078-0432.CCR-07-0992 · DOI
- Lu, 2008, MicroRNA-mediated control of cell fate in megakaryocyte–erythrocyte progenitors, Dev Cell, 14, 843, 10.1016/j.devcel.2008.03.012 · DOI · Paper page
- Martinez, 2008, Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells, Oncogene, 27, 2575, 10.1038/sj.onc.1210919 · DOI · Paper page
- Morgan, 2008, Sequence conservation and differential expression of Marek's disease virus microRNAs, J Virol, 82, 12213, 10.1128/JVI.01722-08 · DOI
- Nazerian, 1987, An updated list of avian cell lines and transplantable tumours, Avian Pathol, 16, 527, 10.1080/03079458708436402 · doi:10.1080/03079458708436402
- Ozen, 2008, Widespread deregulation of microRNA expression in human prostate cancer, Oncogene, 27, 1788, 10.1038/sj.onc.1210809 · DOI · Paper page
- Petherbridge, 2004, Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes, J Virol, 78, 13376, 10.1128/JVI.78.23.13376-13380.2004 · DOI
- Pfeffer, 2004, Identification of virus-encoded microRNAs, Science, 304, 734, 10.1126/science.1096781 · DOI · Paper page
- Pfeffer, 2005, Identification of microRNAs of the herpesvirus family, Nat Methods, 2, 269, 10.1038/nmeth746 · DOI · Paper page
- Pratt, 2009, The microRNAs of Epstein–Barr virus are expressed at dramatically differing levels among cell lines, Virology, 386, 387, 10.1016/j.virol.2009.01.006 · DOI
- Rosenfeld, 2008, MicroRNAs accurately identify cancer tissue origin, Nat Biotechnol, 26, 462, 10.1038/nbt1392 · DOI · Paper page
- Ruike, 2008, Global correlation analysis for micro-RNA and mRNA expression profiles in human cell lines, J Hum Genet, 53, 515, 10.1007/s10038-008-0279-x · DOI
- Schotte, 2008, Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia, Leukemia, 23, 313, 10.1038/leu.2008.286 · DOI · Paper page
- Shaner, 2004, Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein, Nat Biotechnol, 22, 1567, 10.1038/nbt1037 · DOI · Paper page
- Skalsky, 2007, Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155, J Virol, 81, 12836, 10.1128/JVI.01804-07 · DOI · Paper page
- Sullivan, 2007, Identification of viral microRNAs, Methods Enzymol, 427, 3
- Wiemer, 2007, The role of microRNAs in cancer: no small matter, Eur J Cancer, 43, 1529, 10.1016/j.ejca.2007.04.002 · DOI · Paper page
- Xiao, 2007, MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb, Cell, 131, 146, 10.1016/j.cell.2007.07.021 · DOI · Paper page
- Xu, 2008, Analysis of the expression profiles of Marek's disease virus-encoded microRNAs by real-time quantitative PCR, J Virol Methods, 149, 201, 10.1016/j.jviromet.2008.02.005 · DOI
- Yao, 2007, Marek's disease virus type 2 (MDV-2)-encoded microRNAs show no sequence conservation with those encoded by MDV-1, J Virol, 81, 7164, 10.1128/JVI.00112-07 · DOI
- Yao, 2008, MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs, J Virol, 82, 4007, 10.1128/JVI.02659-07 · DOI
- Yeung, 2008, Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1, Cancer Res, 68, 8976, 10.1158/0008-5472.CAN-08-0769 · DOI · Paper page
- Zhao, 2009, A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus, J Virol, 83, 489, 10.1128/JVI.01166-08 · DOI · Paper page
- Zhou, 2007, miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely, Proc Natl Acad Sci U S A, 104, 7080, 10.1073/pnas.0702409104 · DOI · Paper page
Cited by
miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation
Jiao, P., Wang, X.-P., Luoreng, Z.-M., Yang, J., Jia, L., Ma, Y., & Wei, D.-W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59876 · Cited by 151
“In chicken T cells, both Marek’s disease (MD) and overexpressed lnc-GALMD3 result in low miR-223 expression, leading to malignant T cell proliferation [49,50].”
BackgroundExploiting the Therapeutic Potential of MicroRNAs in Viral Diseases: Expectations and Limitations
Hemida, M. G., Ye, X., Thair, S., & Yang, D. (2010) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256383 · Cited by 32
Metadata
- Authors
- Yao, Y., Zhao, Y., Smith, L. P., Lawrie, C. H., Saunders, N. J., Watson, M., & Nair, V.
- Affiliations
- Division of Microbiology, Institute for Animal Health, Compton RG20 7NN, UK
- LRF Molecular Haematology Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford OX3 9DU, UK
- Bacterial Pathogenesis and Functional Genomics Group, Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK
- Venue
- Journal of General Virology
- Publisher
- Microbiology Society
- Published
- 2009-07-01
- Volume
- 90
- Issue
- 7
- Pages
- 1551-1559
- ISSN
- 0022-1317
- 1465-2099
- Cited by
- 60
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.